couter

CRARFCrédit Agricole S.A.

Sep 17, 2026 — ECB Rate Path & NIM Compression Digestion
Chart by TradingView

The schedule

  • Thu17Sep

    As the ECB clarifies its rate trajectory into late 2026, market digestion of potential NIM compression could test the stock. A dovish surprise protecting loan growth could lift shares to $22.10, but our base case models a bearish tilt toward $22.10 as narrowing spreads challenge traditional banking revenue.

  • Fri6Nov

    The Q3 print will reveal whether Crédit Agricole can defend its return on tangible equity (ROTE) targets. Confirming stable corporate loan demand and wealth management inflows should drive a recovery to $21.00, whereas higher non-performing loans (NPLs) would risk a breakdown to $18.50.

  • Fri12Feb

    Full-year results will spotlight the 2027 capital return framework, including potential buybacks and the final dividend payout ratio. A robust distribution announcement could propel the stock to $22.50, while a cautious stance aimed at preserving capital would disappoint income investors, capping the downside at $19.50.

  • Wed5May

    Spring earnings will provide an early read on 2027 operational momentum, particularly how European corporate clients are adapting to President Trump's trade policies. If the bank shows successful cost containment and stabilized margins, shares could reach $23.80. Conversely, a sluggish start to the year or unexpected regulatory capital headwinds could trigger a pullback to $21.00.

Past

  • Fri31Jul

    Actual outcome: Bull · $21.56 at outcome

    Crédit Agricole reported in-line Q2 2026 results, matching EPS estimates of $0.52. Shares ultimately pushed past the $21.20 bull target as resilient fee-generating units and stable asset quality successfully offset broader market concerns regarding net interest margin compression in Europe.

    Crédit Agricole's Q2 2026 results will face scrutiny on net interest margin (NIM) resilience and asset quality amid European economic shifts. We model a favorable path toward $21.20 if fee-generating units offset NIM compression, while a miss on cost of risk or softer guidance could drag shares to the $19.50 support.

  • Fri15May

    Actual outcome: Mixed · $19.53 at outcome

    At its Annual General Meeting and Q1 update, the company confirmed its 2025 dividend and provided steady qualitative guidance on net interest margins and cost of risk. However, the lack of material upside surprises or new capital return initiatives resulted in a muted market reaction, leaving the stock trading relatively flat.

    At its Annual General Meeting and Q1 update, the company confirmed its 2025 dividend and provided steady qualitative guidance on net interest margins and cost of risk. However, the lack of material upside surprises or new capital return initiatives resulted in a muted market reaction, leaving the stock trading relatively flat.